Altered Proteins in the Hippocampus of Patients with Mesial Temporal Lobe Epilepsy
AbstractMesial temporal lobe epilepsy (MTLE) is usually associated with drug-resistant seizures and cognitive deficits. Efforts have been made to improve the understanding of the pathophysiology of MTLE for new therapies. In this study, we used proteomics to determine the differential expression of proteins in the hippocampus of patients with MTLE compared to control samples. By using the two-dimensional electrophoresis method (2-DE), the proteins were separated into spots and analyzed by LC-MS/MS. Spots that had different densitometric values for patients and controls were selected for the study. The following proteins were found to be up-regulated in patients: isoform 1 of serum albumin (ALB), proton ATPase catalytic subunit A (ATP6V1A), heat shock protein 70 (HSP70), dihydropyrimidinase-related protein 2 (DPYSL2), isoform 1 of myelin basic protein (MBP), and dihydrolipoamide S-acethyltransferase (DLAT). The protein isoform 3 of the spectrin alpha chain (SPTAN1) was down-regulated while glutathione S-transferase P (GSTP1) and protein DJ-1 (PARK7) were found only in the hippocampus of patients with MTLE. Interactome analysis of the nine proteins of interest revealed interactions with 20 other proteins, most of them involved with metabolic processes (37%), presenting catalytic activity (37%) and working as hydrolyses (25%), among others. Our results provide evidence supporting a direct link between synaptic plasticity, metabolic disturbance, oxidative stress with mitochondrial damage, the disruption of the blood–brain barrier and changes in CNS structural proteins with cell death and epileptogenesis in MTLE. Besides this, the presence of markers of cell survival indicated a compensatory mechanism. The over-expression of GSTP1 in MTLE could be related to drug-resistance. View Full-Text
Share & Cite This Article
Persike, D.S.; Marques-Carneiro, J.E.; Stein, M.L.L.; Yacubian, E.M.T.; Centeno, R.; Canzian, M.; Fernandes, M.J.S. Altered Proteins in the Hippocampus of Patients with Mesial Temporal Lobe Epilepsy. Pharmaceuticals 2018, 11, 95.
Persike DS, Marques-Carneiro JE, Stein MLL, Yacubian EMT, Centeno R, Canzian M, Fernandes MJS. Altered Proteins in the Hippocampus of Patients with Mesial Temporal Lobe Epilepsy. Pharmaceuticals. 2018; 11(4):95.Chicago/Turabian Style
Persike, Daniele S.; Marques-Carneiro, Jose E.; Stein, Mariana L.L.; Yacubian, Elza M.T.; Centeno, Ricardo; Canzian, Mauro; Fernandes, Maria J.S. 2018. "Altered Proteins in the Hippocampus of Patients with Mesial Temporal Lobe Epilepsy." Pharmaceuticals 11, no. 4: 95.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.